Share：
Share this content in WeChat
X
[Chinese][PDF]3063
• Case Report •
Diffuse midline glioma of cervical spinal cord with H3 K27 alterations: One case report and literature review
DONG Wenjie  ZHOU Fengyu  ZHOU Qing  XUE Caiqiang  ZHANG Peng  ZHOU Junlin 

Cite this article as: DONG W J, ZHOU F Y, ZHOU Q, et al. Diffuse midline glioma of cervical spinal cord with H3 K27 alterations: One case report and literature review[J]. Chin J Magn Reson Imaging, 2023, 14(11): 147-149, 182. DOI:10.12015/issn.1674-8034.2023.11.024.


[Keywords] diffuse midline glioma；H3 K27-altered；cervical spinal cord；magnetic resonance imaging

DONG Wenjie1, 2, 3, 4   ZHOU Fengyu1, 2, 3, 4   ZHOU Qing1, 2, 3, 4   XUE Caiqiang1, 2, 3, 4   ZHANG Peng5   ZHOU Junlin1, 2, 3, 4*  

1 Department of Radiology, the Second Hospital of Lanzhou University, Lanzhou 730000, China

2 Second Clinical School of Lanzhou University, Lanzhou 730000, China

3 Key Laboratory of Medical Imaging of Gansu Province, Lanzhou 730000, China

4 Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou 730000, China

5 Department of Pathology, the Second Hospital of Lanzhou University, Lanzhou 730000, China

Corresponding author: ZHOU J L, E-mail: lzuzjl601@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS National Natural Science Foundation of China (No. 82071872, 82371914); Science and Technology Program of Gansu Province (No. 21YF5FA123); 2021 SKY Imaging Research Fund of China International Medical Foundation (No. Z-2014-07-2101).
Received  2023-04-30
Accepted  2023-09-21
DOI: 10.12015/issn.1674-8034.2023.11.024
Cite this article as: DONG W J, ZHOU F Y, ZHOU Q, et al. Diffuse midline glioma of cervical spinal cord with H3 K27 alterations: One case report and literature review[J]. Chin J Magn Reson Imaging, 2023, 14(11): 147-149, 182. DOI:10.12015/issn.1674-8034.2023.11.024.

[1]
LOUIS D N, PERRY A, REIFENBERGER G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820. DOI: 10.1007/s00401-016-1545-1.
[2]
LOUIS D N, PERRY A, WESSELING P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary[J]. Neuro Oncol, 2021, 23(8): 1231-1251. DOI: 10.1093/neuonc/noab106.
[3]
LÓPEZ-PÉREZ C A, FRANCO-MOJICA X, VILLANUEVA-GAONA R, et al. Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity[J]. J Neurooncol, 2022, 158(3): 369-378. DOI: 10.1007/s11060-022-04024-5.
[4]
LOUIS D N, GIANNINI C, CAPPER D, et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant[J]. Acta Neuropathol, 2018, 135(4): 639-642. DOI: 10.1007/s00401-018-1826-y.
[5]
SOLOMON D A, WOOD M D, TIHAN T, et al. Diffuse Midline gliomas with histone H3-K27M mutation: A series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations[J]. Brain Pathol, 2016, 26(5): 569-580. DOI: 10.1111/bpa.12336.
[6]
KARREMANN M, GIELEN G H, HOFFMANN M, et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location[J]. Neuro Oncol, 2018, 20(1): 123-131. DOI: 10.1093/neuonc/nox149.
[7]
SEKI T, HIDA K, YANO S, et al. Surgical outcomes of high-grade spinal cord gliomas[J]. Asian Spine J, 2015, 9(6): 935-941. DOI: 10.4184/asj.2015.9.6.935.
[8]
NAKAMURA M, CHIBA K, ISHII K, et al. Surgical outcomes of spinal cord astrocytomas[J]. Spinal Cord, 2006, 44(12): 740-745. DOI: 10.1038/sj.sc.3101932.
[9]
WU X Y, HUANG C Y, LUO W, et al. Clinicopathological characteristics and prognosis of diffuse midline glioma of the spinal cord with H3K27M mutation[J]. Journal of Molecular Diagnosis and Therapy, 2022, 14(8) : 1324-1328, 1333. DOI: 10.19930/j.cnki.jmdt.2022.08.038.
[10]
PENG J, SHAN Y, QI Z G, et al. Diffuse the midline glioma with MRI manifestation of H3 K27M mutations[J]. Radiol Prac, 2021, 4(11): 1351-1355. DOI: 10.13609/j.cnki.1000-0313.2021.11.003.
[11]
ZHANG Y Y, XIAO H, YANG T, et al. H3K27M mutant diffuse midline glioma MRI performance[J]. J Clin Radiol, 2021, 40(1): 16-20. DOI: 10.13437/j.cnki.jcr.2021.01.004.
[12]
YE H, HE P, SUN Y H, et al. Diffuse midline glioma with H3K27M mutation: report of four cases and literature review[J]. Diagnostic Imaging & Interventional Radiology, 2018, 27(5): 380-383. DOI: 10.3969/j.issn.1005-8001.2018.05.009.
[13]
GU Q, HUANG Y, ZHANG H, et al. Case report: Five adult cases of H3K27-altered diffuse midline glioma in the spinal cord[J]. Front Oncol, 2021, 11: 701113. DOI: 10.3389/fonc.2021.701113.
[14]
ABOIAN M S, SOLOMON D A, FELTON E, et al. Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation[J]. AJNR Am J Neuroradiol, 2017, 38(4): 795-800. DOI: 10.3174/ajnr.A5076.
[15]
YOSHIMOTO K, HATAE R, SANGATSUDA Y, et al. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution[J]. Brain Tumor Pathol, 2017, 34(3): 103-112. DOI: 10.1007/s10014-017-0287-7.
[16]
BAYLISS J, MUKHERJEE P, LU C, et al. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas[J/OL]. Sci Transl Med, 2016, 8(366): 366ra161 [2023-04-29]. https://pubmed.ncbi.nlm.nih.gov/27881822/. DOI: 10.1126/scitranslmed.aah6904.
[17]
BECHET D, GIELEN GG, KORSHUNOV A, et al. Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas[J]. Acta Neuropathol, 2014, 128(5): 733-741. DOI: 10.1007/s00401-014-1337-4.

PREV Diagnostic value of diffusion weighted imaging and conventional magnetic resonance imaging on parotid gland tumors
NEXT Advances in the application of magnetic resonance imaging in the localization of therapeutic targets for transcranial magnetic stimulation in depression
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn